Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-012525
Filing Date
2013-02-25
Accepted
2013-02-25 20:07:11
Documents
1
Period of Report
2013-02-21

Document Format Files

Seq Description Document Type Size
1 rrd371537.html 4  
1 rrd371537.xml 4 6058
  Complete submission text file 0001181431-13-012525.txt   7595
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SAGENT PHARMACEUTICALS,INC. 1901 N. ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
Logerfo Michael (Reporting) CIK: 0001518010 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 13640728